Hypothalamic WNT signalling is impaired during obesity and reinstated by leptin treatment in male mice

Endocrinology

Volumn 154, Issue 12, 2013, Pages 4737-4745

  Benzler, Jonas ^a   Andrews, Zane B ^b   Pracht, Corinna ^a   Stöhr, Sigrid ^a   Shepherd, Peter R ^c   Grattan, David R ^d   Tups, Alexander ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b MONASH UNIVERSITY   (Australia)

^c MAURICE WILKINS CENTRE FOR MOLECULAR BIODISCOVERY   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; CYCLIN D1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MESSENGER RNA; NEUROPEPTIDE Y; WNT PROTEIN; ANDROGEN RECEPTOR; CHROMATIN; LEPTIN; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; GLUCOSE INTOLERANCE; IMMUNOCOMPETENT CELL; IN SITU HYBRIDIZATION; LEPTIN DEFICIENCY; LIPID DIET; MALE; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; WEIGHT GAIN; WNT SIGNALING PATHWAY; AGING; ANIMAL; CHROMATIN; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; HYPOTHALAMUS; INBRED MOUSE STRAIN; METABOLISM; NEWBORN; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; TESTIS;

AGING; ANIMALS; ANIMALS, NEWBORN; CHROMATIN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPOTHALAMUS; LEPTIN; MALE; MICE; MICE, INBRED STRAINS; MYOCARDIUM; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, ANDROGEN; TESTIS; TESTOSTERONE; WNT SIGNALING PATHWAY;

EID: 84888269219     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1746     Document Type: Article

References (39)

1. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129-2140.
2. Marks JL, Porte D Jr, Stahl WL, Baskin DG. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology. 1990;127:3234-3236.
3. Brüning JC, Gautam D, Burks DJ, et al. Role of brain insulin receptor in control of body weight and reproduction. Science. 2000;289:2122-2125.
4. Moon RT, Brown JD, Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet. 1997;13:157-162.
5. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science. 2000;287:1606-1609.
6. Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006;355:241-250.
7. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320-323.
8. Kiessling A, Ehrhart-Bornstein M. Transcription factor 7-like 2 (TCFL2)-a novel factor involved in pathogenesis of type 2 diabetes. Comment on: Grant et al., Nat Genet. 2006. Horm Metab Res. 2006;38:137-138.
9. Anagnostou SH, Shepherd PR. Glucose induces an autocrine activation of the Wnt/β-catenin pathway in macrophage cell lines. Biochem J. 2008;416:211-218.
10. MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and disases. Dev Cell. 2009;17:9-26.
11. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785-789.
12. Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation. Biochem J. 1994;303(Pt 3):701-704.
13. Sutherland C, Leighton IA, Cohen P. Inactivation of glycogen synthase kinase-3β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J. 1993;296(Pt 1):15-19.
14. Cline GW, Johnson K, Regittnig W, et al. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes. 2002;51:2903-2910.
15. Kaidanovich-Beilin O, Eldar-Finkelman H. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle. J Pharmacol Exp Ther. 2006;316:17-24.
16. Benzler J, Ganjam GK, Kruger M, et al. Hypothalamic glycogen-synthase- kinase 3β has a central role in the regulation of food intake and glucose metabolism. Biochem J. 2012;447:175-184.
17. Koch C, Augustine RA, Steger J, et al. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. J Neurosci. 2010;30:16180-16187.
18. Mercer JG, Moar KM, Logie TJ, Findlay PA, Adam CL, Morgan PJ. Seasonally inappropriate body weight induced by food restriction: effect on hypothalamic gene expression in male Siberian hamsters. Endocrinology. 2001;142:4173-4181.
19. Paxinos G, Franklin K. The Mouse Brain in Stereotaxic Coordinates; San Diego, CA: Academic Press; 2002.
20. Tups A, Anderson GM, Rizwan M, et al. Both p110α and p110β isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus. J Neuroendocrinol. 2010;22:534-542.
21. Tamai K, Semenov M, Kato Y, et al. LDL-receptor-related proteins in Wnt signal transduction. Nature. 2000;407:530-535.
22. Morton GJ, Schwartz MW. The NPY/AgRP neuron and energy homeostasis. Int J Obes Relat Metab Disord. 2001;25(Suppl 5):S56-S62.
23. Schwartz MW,Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661-671.
24. van den Hoek AM, Voshol PJ, Karnekamp BN, et al. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes. 2004;53:2529-2534.
25. Cerpa W, Godoy JA, Alfaro I, et al. Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons. J Biol Chem. 2008;283:5918-5927.
26. Lyons JP, Mueller UW, Ji H, et al. Wnt-4 activates the canonical β-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/β-catenin activity in kidney epithelial cells. Exp Cell Res. 2004;298:369-387.
27. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172-1183.
28. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422-426.
29. German JP, Wisse BE, Thaler JP, et al. Insulin resistance induced by uncontrolled diabetes is mediated by leptin deficiency. Diabetes. 2010;59:1626-1634.
30. Hedbacker K, Birsoy K, Wysocki RW, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab. 2010;11:11-22.
31. Li Z, Shen J,Wu WK, et al. Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways. PLoS One. 2012;7:e53176.
32. Valerio A, Ghisi V, Dossena M, et al. Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3β. J Biol Chem. 2006;281:12950-12958.
33. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci. 2002;5:566-572.
34. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med. 2002;8:1376-1382.
35. Gelling RW, Morton GJ, Morrison CD, et al. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metab. 2006;3:67-73.
36. Koch L, Wunderlich FT, Seibler J, et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest. 2008;118:2132-2147.
37. Zhou T, Zhou KK, Lee K, et al. The role of lipid peroxidation products and oxidative stress in activation of the canonical winglesstype MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy. Diabetologia. 2010;54:459-468.
38. Mani A, Radhakrishnan J, Wang H, et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science. 2007;315:1278-1282.
39. Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004;29:95-102.